Jennifer Sharpe Potter, Ph.D., M.P.H



Jennifer Sharpe Potter, Ph.D., M.P.H, . is an Assistant Professor in the Department of Psychiatry. Dr. Potter joined UT Health Science Center from Harvard Medical School and McLean Hospital in Belmont, Massachusetts at which she continues to hold research appointments. Dr. Potter received a Ph.D. in clinical psychology from the University of Georgia and a Master of Public Health from Emory University. She completed her pre-doctoral clinical internship and research fellowship at McLean Hospital and Harvard Medical School. Throughout her career, Dr. Potter has been involved with multi-disciplinary, cross-institutional collaborative research. This is illustrated by her current collaborations with health services, public health, and neuroscience researchers located at UT Health Science Center and at institutions throughout the United States.

Dr. Potters primary clinical interest is opioid use behaviors in individuals with pain and substance use disorders. Dr. Potter seeks to develop empirically-supported treatments integrating behavioral and medication-based treatments for substance use disorders. Her current research focuses on two main areas: (1) understanding the role of pain-related cognitive, behavioral, and physiological processes in opioid use behaviors; and (2) identifying mechanisms of behavior change, amenable to intervention, based on these processes. In addition to her community-based clinical research, Dr. Potter established the Opioid, Pain, and Addiction Laboratory (OPAL) to examine pain and opioid use behaviors using experimental paradigms that afford more control than is feasible in applied research.


Dr. Potters research is supported primarily with two NIDA grants: (1) a K23 career development award (K23DA022297-04/Potter) examining treatment of chronic pain and opioid dependence; and (2) the Clinical Trials Network (CTN) Texas Node (U10DA020024/Trivedi-UT Southwestern) for which she is a Co-Investigator and the Institutional Principal Investigator at UT Health Science Center San Antonio. The CTN conducts Phase 3 clinical trials of pharmacological and behavioral treatments for substance use disorders in community settings. Dr. Potter served as the National Project Director for the CTN Prescription Opioid Addiction Treatment Study (POATS), the largest multisite clinical trial ever conducted to examine treatment of prescription opioid dependence in individuals with and without co-occurring chronic pain. A three-year follow-up study of POATS participants is currently underway.



To view faculty profile:



Jennifer Sharpe Potter, Ph.D.
Associate Professor, UTHSCSA
UT Health Science Center School of Medicine – Psychiatry
7526 Floyd Curl Dr.
San Antonio, TX 78229
Phone:  (210) 562-5438
Fax: (210) 562-5403
email: potterjs@uthscsa.edu